Skip to search formSkip to main contentSkip to account menu

HE3286

Known as: HE-3286 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Combined inhibition of angiotensin II type 1 receptor and ASK1 significantly attenuates autoimmune optic neuritis
Program Number: 5769 Poster Board Number: B0105 Presentation Time: 8:30 AM–10:15 AM Combined inhibition of angiotensin II type 1… 
2011
2011
Studies of the pharmacology of 17α-ethynyl-androst-5-ene-3β,7β,17β-triol, a synthetic anti-inflammatory androstene.
17α-Ethynyl-androst-5ene-3β, 7β, 17β-triol (HE3286) is an orally bioavailable analogue of androst-5-ene-3β,7β,17β-triol, a non… 
2011
2011
HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse.
2010
2010
HE3286, an oral synthetic steroid, treats lung inflammation in mice without immune suppression
Background17α-Ethynyl-5-androsten-3β, 7β, 17β-triol (HE3286) is a synthetic derivative of an endogenous steroid androstenetriol… 
2008
2008
17a‐ethynyl‐5‐androsten‐3ß, 7ß, 17ß‐triol (HE3286): a novel synthetic steroid with broad based anti‐inflammatory activity
HE3286 is a novel synthetic steroid that limits acute and chronic inflammation in rodents. HE3286 limited carrageenan‐induced… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)